5 Best 52-Week Low Small-Cap Stocks to Buy Now

3. Cerus Corporation (NASDAQ:CERS)

Number of Hedge Fund Holders: 19

Cerus Corporation (NASDAQ:CERS) is a Concord, California-based biotechnology company involved in developing and providing pathogen-protected blood components to blood centers and hospitals.

Cerus Corporation’s (NASDAQ:CERS) Intercept Blood System for platelets and plasma is the only pathogen reduction system that has received approval from the FDA along with a CE mark that reflects the conformity to the European standards of health and safety. Cerus Corporation (NASDAQ:CERS) has agreed on a five-year extension with the American Red Cross for the Intercept System. The American Red Cross is responsible for providing nearly 40% of all the blood in the US. On the other hand, the company has also signed an agreement with Fresenius Kabi to produce the Intercept Kits for the next decade. The company’s bright future prospects justify its position in our list of the 10 best 52-week low small-cap stocks to buy now.

Baker Bros. Advisors was the leading hedge fund investor in Cerus Corporation (NASDAQ:CERS) during Q2 2022.